With retatrutide producing 28.3% average weight loss over 80 weeks, the scale of fat oxidation involved is substantial and so is the associated heat generation
Retatrutide targets this visceral fat preferentially due to the glucagon receptor component, potentially offering outsized testosterone benefits compared to weight loss that primarily affects subcutaneous fat
Discussion In this analysis, the proportion of semaglutide or tirzepatide prescriptions associated with a diagnosis of PCOS increased modestly between 2021 and 2025, from 4.6% to 5.7%
This article outlines what is currently known about retatrutide's adverse effects, addresses questions around libido and sexual health, and explains when to seek medical advice in the UK context
Combining medications can increase the risk of side effectsespecially gastrointestinal symptoms like nausea and vomitingand there may be unknown interactions between drugs
Shed also offers a Membership Program for those taking Zepbound or Wegovy